
    
      Trastuzumab will be administered at a loading dose of 8 mg/kg (on day 1) followed by 6mg/kg
      i.v. infusion every 3 weeks.

      Trastuzumab is to be continued until disease progression or intolerable toxicity.

      Capecitabine (Xeloda) 2000mg/m2d, d1-14; q3w, until disease progression or intolerable
      toxicity.

      Oxaliplatin 130mg/m2 d1; q3w, 6 cycles
    
  